226 related articles for article (PubMed ID: 15959825)
21. [Evaluation of paclitaxel and carboplatin in patients with endometrial cancer].
Nakamura T; Onishi Y; Yamamoto F; Kouno S; Maeda Y; Hatae M
Gan To Kagaku Ryoho; 2000 Feb; 27(2):257-62. PubMed ID: 10700897
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
Volgger B; Zeimet AG; Reinthaller A; Petru E; Schauer C; Klein M; Sevelda-Schwarzgruber U; Bogner G; Wolfram G; Marth C
Int J Gynecol Cancer; 2015 Feb; 25(2):257-62. PubMed ID: 25611899
[TBL] [Abstract][Full Text] [Related]
23. Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer.
Akram T; Maseelall P; Fanning J
Am J Obstet Gynecol; 2005 May; 192(5):1365-7. PubMed ID: 15902110
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer.
Torfs S; Cadron I; Amant F; Leunen K; Berteloot P; Vergote I
Eur J Cancer; 2012 Jun; 48(9):1332-40. PubMed ID: 22317951
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study.
Hoskins PJ; Swenerton KD; Pike JA; Wong F; Lim P; Acquino-Parsons C; Lee N
J Clin Oncol; 2001 Oct; 19(20):4048-53. PubMed ID: 11600606
[TBL] [Abstract][Full Text] [Related]
26. A pilot study of combination chemotherapy with paclitaxel, pirarubicin, and carboplatin (TPC) for endometrial carcinoma.
Hongo A; Kusumoto T; Nakamura K; Seki N; Kodama J; Hiramatsu Y
Int J Clin Oncol; 2010 Oct; 15(5):476-83. PubMed ID: 20526888
[TBL] [Abstract][Full Text] [Related]
27. Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naïve women with high-grade epithelial cancers of Mullerian origin.
Kudlowitz D; Velastegui A; Musa F; Muggia F
Cancer Chemother Pharmacol; 2018 May; 81(5):847-851. PubMed ID: 29516152
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Papadimitriou CA; Bafaloukos D; Bozas G; Kalofonos H; Kosmidis P; Aravantinos G; Fountzilas G; Dimopoulos MA;
Gynecol Oncol; 2008 Jul; 110(1):87-92. PubMed ID: 18455782
[TBL] [Abstract][Full Text] [Related]
29. [Combination chemotherapy with paclitaxel and carboplatin (TC therapy) for endometrial cancer].
Misawa A; Nagao M; Kushimoto T; Yasuda M
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1901-5. PubMed ID: 19011339
[TBL] [Abstract][Full Text] [Related]
30. Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).
Nomura H; Aoki D; Takahashi F; Katsumata N; Watanabe Y; Konishi I; Jobo T; Hatae M; Hiura M; Yaegashi N
Ann Oncol; 2011 Mar; 22(3):636-642. PubMed ID: 20696677
[TBL] [Abstract][Full Text] [Related]
31. A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer.
Kitagawa R; Katsumata N; Ando M; Shimizu C; Fujiwara Y; Yoshikawa H; Satoh T; Nakanishi T; Ushijima K; Kamura T
Gynecol Oncol; 2012 May; 125(2):307-11. PubMed ID: 22333993
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group.
van Wijk FH; Lhommé C; Bolis G; Scotto di Palumbo V; Tumolo S; Nooij M; de Oliveira CF; Vermorken JB;
Eur J Cancer; 2003 Jan; 39(1):78-85. PubMed ID: 12504662
[TBL] [Abstract][Full Text] [Related]
33. Docetaxel and carboplatin combination chemotherapy for recurrent endometrial cancer.
Obata H; Aoki Y; Watanabe M; Matsushita H; Yahata T; Fujita K; Kurata H; Tanaka K
Int J Clin Oncol; 2003 Feb; 8(1):53-5. PubMed ID: 12601544
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.
Yoo HJ; Lim MC; Lim S; Park JY; Kang S; Park SY; Seo SS
Arch Gynecol Obstet; 2012 Dec; 286(6):1529-35. PubMed ID: 22825691
[TBL] [Abstract][Full Text] [Related]
35. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Papadimitriou CA; Fountzilas G; Bafaloukos D; Bozas G; Kalofonos H; Pectasides D; Aravantinos G; Bamias A; Dimopoulos MA;
Gynecol Oncol; 2008 Oct; 111(1):27-34. PubMed ID: 18644619
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
38. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
Duska LR; Berkowitz R; Matulonis U; Muto M; Goodman A; McIntyre JF; Klein A; Atkinson T; Seiden MV; Campos S
Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA).
Moreira E; Paulino E; Ingles Garces ÁH; Fontes Dias MS; Saramago M; de Moraes Lino da Silva F; Thuler LCS; de Melo AC
Med Oncol; 2018 Jan; 35(3):20. PubMed ID: 29387971
[TBL] [Abstract][Full Text] [Related]
40. Prolonged remission of endometrial cancer with paclitaxel and carboplatin.
Vasuratna A; Kudelka AP; Edwards CL; Wootipoom V; Verschraegen CF; Charnsangavej C; Kavanagh JJ
Anticancer Drugs; 1998 Mar; 9(3):283-5. PubMed ID: 9625439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
